STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET
STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET
复制标题
DOI:
10.1007/bf00212840
复制
发表时间:
1988-01-01
影响因子:
3.4
通讯作者:
STONEELANDER, S
中科院分区:
文献类型:
--
作者:
FARDE, L;PAULI, S;STONEELANDER, S
The selective D2-dopamine receptor antagonist raclopride and its pharmacologically inactive (R)-enatiomer FLB472 were labelled with 11C and used in a study with positron emission tomography to examine the stereoselectivity of 11C-raclopride binding to central D2-dopamine receptors in three healthy men. After the injection of 11C-raclopride, there was a high accumulation of radioactivity in the dopamine-rich basal ganglia, whereas after the injection of 11C-FLB472 there was no such accumulation of radioactivity. Thus, the binding of 11C-raclopride is stereoselective. Distribution ratios [radioactivity in a brain region/"free" (not protein-bound) radioactivity in plasma] were calculated for the two enantiomers to study regional differences in the accumulation of radioactivity. The distribution ratios in white matter were similar for the two enantiomers. In the putamen, a three to four-fold higher distribution ratio was found for 11C-raclopride than for 11C-FLB472, reflecting the presence of specific binding of 11C-raclopride binding to D2-dopamine receptors in the basal ganglia. In the temporal and frontal cortices the distribution ratios were, however, only a few per cent higher for 11C-raclopride than for 11C-FLB472, indicating that if D2-dopamine receptors are present in the human neocortex, then their density is indeed very low.